TABLE 1:

Baseline characteristics, time to intervention, angiographic findings, and outcomes

Patient/Age/SexOnset to (min)UK Dose (U)Arterial lesion on DSAFinal TIMI GradeNIHSS ScoremRS Score 90 DayHT
rTPADSABaseline30 Day
1/59/F120270800,000Distal ICA2952No
2/61/M210290800,000BA32810No
3/53/F60120500,000M131421No
4/74/F195300300,000M202200Asym
5/76/F170260500,000M131310No
6/82/M100NANANANA3000No
7/62/M75110700,000M132531No
8/60/F90160600,000M1219104Asym
9/52/M90160NAM1 stenosis3800No
10/47/M9060*800,000BA31500No
11/48/M130210*NANormal3720No
12/78/M175NANANANA9NA6No
13/74/F120240800,000M131773Asym
14/65/F150210400,000Distal ICA022255Asym
15/63/M145210800,000M132272No
16/61/M140NANANANA711No
17/78/M105205NACervical ICA019NA5No
18/70/M150270600,000M122392No
19/81/M130230NADistal ICA stenosis32321No
20/67/M130NANANANA4306Sym
21/71/F701601,000,000Distal ICA123NA6Sym
22/59/F170290NANormal32111No
23/80/M160NANANANA1641No
24/60/F170310500,000M1017154Asym
25/59/M110230NACervical ICA022NA2No
26/54/M150275500,000Distal ICA32041No
27/72/F150255NAPCA01731No
28/58/F180265500,000M131300No
29/57/M135NANANANA811No
30/81/M150250NABA stenosis32411No
  • Note.—Asym indicates asymptomatic hemorrhagic transformation; DSA, digital subtraction angiography; M1, M1 segment of the MCA; M2, M2 segment of the MCA; NA, not applicable; and Sym, symptomatic hemorrhagic transformation.

  • * Time from recurrent symptoms after IV thrombolysis to angiography.